CAY 10465 is primarily utilized in research settings as a potent and selective inhibitor of the enzyme soluble epoxide hydrolase (sEH). Its application is significant in the study of inflammation, cardiovascular diseases, and pain management. By inhibiting sEH, it helps in increasing the levels of epoxyeicosatrienoic acids (EETs), which are known to have anti-inflammatory, vasodilatory, and analgesic properties. This makes CAY 10465 a valuable tool in preclinical studies aimed at understanding the role of sEH in various disease models and exploring potential therapeutic interventions.